Search filters

AFINUM acquires majority stake in Swiss Interconnect Group

AFINUM Achte Beteiligungsgesellschaft mbH & Co. KG has acquired a majority stake in the Swiss Interconnect Group with headquarters in the canton of Valais, Switzerland. The Swiss Interconnect Group is a leading provider of high...

Resistell Closes Series A Financing Round

Resistell AG has closed a milestone-based CHF 3.5 million Series A Financing round led by OCCIDENT. TRUMPF Venture, Alpana Ventures, Zürcher Kantonalbank, HEMEX and seven private investors also back the start-up developing world’s...

IMCD Switzerland acquires DCS Pharma

IMCD N.V., a Dutch leading distributor of specialty chemicals and food ingredients acquired Swiss based pharmaceutical distributor DCS Pharma AG through its Swiss subsidiary IMCD Switzerland AG. The staggered acquisition structure...

Numab and Sunshine Guojian form partnership

3SBio Inc.’s subsidiary Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (“Sunshine Guojian”) and Numab have formed a partnership focusing on the development and commercialization of a portfolio of novel multi-specific...

ARTIDIS announces CHF 8.8M seed financing round

ARTIDIS AG ("ARTIDIS"), a privately held healthtech company, announced the successful closure of a CHF 8.8M seed financing in two rounds, securing early clinical validation and the next development phase towards market entry in...

Kuros Biosciences AG completes rights offering and share placement

Kuros Biosciences (SIX: KURN) completes a rights offering and share placement in which a total of 6,405,022 new registered shares of Kuros sourced from the ordinary and authorized share capital with a nominal value of CHF 1.00...

ImmunOs Therapeutics AG raises CHF 15M in Series A Financing

ImmunOs Therapeutics AG, a Swiss biotechnology company and leading developer of a next generation innate immunity focused immunotherapy platform for cancer, announced today the closing of a Series A financing of CHF 15 million....

Public Offer of BFW Holding AG for BFW Liegenschaften AG

On November 29, 2019 BFW Holding AG published a friendly public offer for the SIX listed A shares of BFW Liegenschaften AG (going private). VISCHER (partners Felix W. Egli and Adrian Dörig as well as associates Sebastian Flückiger...

EraCal Therapeutics AG Closes Seed Financing Round

EraCal Therapeutics AG, established as a spin-off from the University of Zurich and Harvard University, completes an oversubscribed seed financing round. Investors included Bernina BioInvest, Redalpine, the UZH Life Sciences Fund...

Sale of 3 Plus Group to CH-Media

VISCHER advised 3 Plus Group, the largest private TV group in Switzerland, on all legal and tax matters regarding its sale to CH-Media. VISCHER also advised the shareholders of 3 Plus Group regarding all tax matters in this...

You are currently offline. Some pages or content may fail to load.